WHO ICTRP trial
Pharmacokinetics and Effect of Magnesium Sulfate in Early Onset Severe…
ChiCTR1800017045 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1800017045 |
|---|---|
| Public title | Pharmacokinetics and Effect of Magnesium Sulfate in Early Onset Severe Preeclamptic Patients |
| Scientific title | Pharmacokinetics and Effect of Magnesium Sulfate in Early Onset Severe Preeclamptic Patients |
| Primary sponsor | Suzhou Hospital Affiliated to Nanjing Medical University/ Suzhou Municipal Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Other |
| Countries | China |
| Conditions | Early Onset Severe Preeclampsia |
| Interventions | Case series:To use Magnesium Sulfate to treat Early Onset Severe Preeclampsia |
| Registration date | Jul 10, 2018 |
| Target size | Case series:24 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: